0001209191-19-024315.txt : 20190410
0001209191-19-024315.hdr.sgml : 20190410
20190410194537
ACCESSION NUMBER: 0001209191-19-024315
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190408
FILED AS OF DATE: 20190410
DATE AS OF CHANGE: 20190410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Popovits Kimberly J
CENTRAL INDEX KEY: 0001333482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 19742613
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-08
0
0001131324
GENOMIC HEALTH INC
GHDX
0001333482
Popovits Kimberly J
301 PENOBSCOT DR.
REDWOOD CITY
CA
94063
1
1
0
0
President and CEO
Common Stock
2019-03-29
5
G
0
E
7000
0.00
D
118952
I
Held by the Popovits 2010 Trust
Common Stock
2019-04-08
4
S
0
7536
66.7216
D
111416
I
Held by the Popovits 2010 Trust
Common Stock
2019-04-08
4
S
0
2364
67.545
D
109052
I
Held by the Popovits 2010 Trust
Common Stock
2019-04-08
4
S
0
100
68.31
D
108952
I
Held by the Popovits 2010 Trust
Common Stock
12298
I
Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits
Common Stock
36168
D
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $66.29 to $67.25.
Represents weighted average sale price. Actual sale prices ranged from $67.30 to $68.03.
Represents actual sale price.
Represents shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
/s/ Jason W. Radford, Attorney-in-fact
2019-04-10